Tagraxofusp

Elzonris

Treatment Description

Tagraxofusp is a first-in-class CD123 fusion protein that is approved for treatment in Blastic Plasmacytoid Dendritic Cell Neoplasm.

There are 25 centers running trials with this treatment. Enter a location below to find the closest center.